The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,959.00
Bid: 1,952.00
Ask: 1,954.00
Change: 20.00 (1.03%)
Spread: 2.00 (0.102%)
Open: 1,940.00
High: 1,971.00
Low: 1,940.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Bernstein Raises ITV And Sky To Outperform

Tue, 13th Jan 2015 09:56

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Mondays
----------
FTSE 100
----------
BERNSTEIN RAISES ITV TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 250 (220) PENCE
----------
BERNSTEIN RAISES SKY TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 1050 (900) PENCE
----------
S&P CAPITAL IQ CUTS SHIRE TO 'BUY' ('STRONG BUY') - TARGET 5350 (4700) PENCE
----------
UBS RAISES BURBERRY PRICE TARGET TO 1650 (1510) PENCE - 'NEUTRAL'
----------
Investec Lifts BAE Systems Price Target to 440P From 430P, Keeps Sell
----------
Investec Raises Meggitt Price Target To 560P From 540P, Keeps At Buy
----------
UBS RAISES MEGGITT PRICE TARGET TO 510 (490) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES GKN PRICE TARGET TO 410 (380) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES TESCO PRICE TARGET TO 185 (145) PENCE - 'UNDERWEIGHT'
----------
EXANE BNP CUTS CENTRICA PRICE TARGET TO 275 (330) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES VODAFONE PRICE TARGET TO 285 (280) PENCE - 'BUY'
----------
JEFFERIES INITIATES TULLOW OIL WITH 'UNDERPERFORM' - TARGET 345 PENCE
----------
BARCLAYS REINITIATES LONDON STOCK EXCHANGE LSE WITH 'OVERWEIGHT'
----------
BARCLAYS PUTS LONDON STOCK EXCHANGE LSE AUF 2550 PENCE
----------
CREDIT SUISSE RAISES ANTOFAGASTA TO 'NEUTRAL' ('UNDERPERFORM')
----------
BARCLAYS RAISES TAYLOR WIMPEY PRICE TARGET TO 147,6 (142,6) P - 'OVERWEIGHT'
----------
BERNSTEIN CUTS CENTRICA PRICE TARGET TO 270 (290) PENCE - 'MARKET-PERFORM'
----------
BERNSTEIN RAISES SEVERN TRENT TO 'OUTPERFORM' ('MARKET-PERFORM') - TP 2250 (1910) PENCE
----------
BERNSTEIN RAISES UNITED UTILITIES PRICE TARGET TO 1010 (980) P - 'OUTPERFORM'
----------
BERNSTEIN RAISES NATIONAL GRID PRICE TARGET TO 1010 (960) PENCE - 'OUTPERFORM'
----------
BERNSTEIN RAISES SSE PRICE TARGET TO 1450 (1330) PENCE - 'UNDERPERFORM'
----------
Liberum Raises Reed Elsevier Price Target To 1,300P, Rates At Buy
----------
Cantor Fitzgerald Raises WM Morrison Price Target To 200P, Keeps Buy
----------
JEFFERIES RAISES IAG PRICE TARGET TO 570 (480) PENCE - 'BUY'
----------
JEFFERIES RAISES EASYJET PRICE TARGET TO 1850 (1750) PENCE - 'BUY'
----------
FTSE 250
----------
JPMORGAN RAISES LAIRD PRICE TARGET TO 363 (318) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS RESTAURANT GROUP PRICE TARGET TO 730 (745) PENCE - 'OVERWEIGHT'
----------
SHORE CAPITAL INITIATES MAN GROUP WITH 'BUY'
----------
GOLDMAN RAISES MAN GROUP PRICE TARGET TO 185 (125) PENCE - 'NEUTRAL'
----------
SHORE CAPITAL INITIATES HENDERSON GROUP PLC WITH 'BUY'
----------
SHORE CAPITAL INITIATES JUPITER FUND WITH 'SELL'
----------
DAVY CUTS CENTAMIN PRICE TARGET TO 74 (77) PENCE - 'OUTPERFORM'
----------
NUMIS CUTS AVEVA GROUP PRICE TARGET TO 1740 (1810) PENCE - 'BUY'
----------
UBS RAISES TATE & LYLE TO 'BUY' ('NEUTRAL') - PRICE TARGET 680 (615) PENCE
----------
UBS RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 2700 (2200) PENCE - 'BUY'
----------
UBS CUTS AFREN PRICE TARGET TO 32 (55) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES CABLE & WIRELESS PRICE TARGET TO 70 (68) PENCE - 'BUY'
----------
GOLDMAN RAISES TALK TALK TELECOM PRICE TARGET TO 474,40 (419) PENCE - 'NEUTRAL'
----------
LIBERUM CUTS COBHAM TO 'HOLD' ('BUY') - TARGET 330 PENCE
----------
CREDIT SUISSE CUTS KAZ MINERALS TO 'UNDERPERFORM' ('NEUTRAL')
----------
BARCLAYS CUTS GREENE KING PRICE TARGET TO 835 (900) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HOMESERVE PRICE TARGET TO 223 (211) PENCE - 'UNDERWEIGHT'
----------
TRADERS: NUMIS CUTS CINEWORLD TO 'HOLD' ('ADD') - TARGET 420 PENCE
----------
BERNSTEIN RAISES DRAX TO 'OUTPERFORM' ('UNDERPERFORM') - TARGET 420 (550) PENCE
----------
Cantor Fitzgerald Raises Debenhams Price Target To 70P, Keeps At Hold
----------
Investec Cuts Debenhams To Sell From Hold, Price Target 66p
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS LAMPRELL PRICE TARGET TO 154 (180) PENCE - 'OVERWEIGHT'
----------
PANMURE CUTS BORDERS & SOUTHERN PETROLEUM PRICE TARGET TO 40 (50) PENCE - 'BUY'
----------
PANMURE CUTS FAROE PETROLEUM PRICE TARGET TO 180 (200) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.